Corcept Therapeutics · 2 days ago
Manufacturing Intern
Corcept Therapeutics is a leading company in the research and development of cortisol modulators. They are seeking a Manufacturing Intern to support the Manufacturing Team in various activities related to the production of clinical trial materials and commercial products.
BiotechnologyMedicalPharmaceutical
Responsibilities
Review and collate manufacturing data to develop metrics, control charts and analysis to improve manufacturing processes
Support Proven Acceptable Range (PAR) Study protocols, reports and analysis to optimize manufacturing processes
Present metric updates to management and project stakeholders
Maintain current, accurate and complete manufacturing files (hard copy & electronic, as appropriate)
Review regulatory submissions for accuracy and completeness
Handle confidential information and perform duties in strict confidence
Ability to multitask with varying priorities
Other Duties as assigned
Develop strong collaborative relationship with internal groups, such as Manufacturing, Supply Chain and Analytical Development
Deliver a department presentation at the end of the program
Participate as a member of the 2026 intern team group project that includes a company-wide presentation
Qualification
Required
Excellent organizational, problem solving and communication skills
Able to perform detailed work accurately and in a timely manner
Must be able to complete at least 10 consecutive weeks between June and August and it is a full-time internship (40 hours per week)
Must be able to work at our Redwood City office for the duration of the internship, no relocation available
Applicants must be currently authorized to work in the United States on a full-time basis
Preferred
Proficient in Microsoft Power Point, Word & Excel
Company
Corcept Therapeutics
Corcept Therapeutics discovers and develops drugs that regulate the effects of cortisol.
Funding
Current Stage
Public CompanyTotal Funding
$119.09MKey Investors
Paperboy Ventures
2012-07-02IPO
2012-04-10Post Ipo Equity· $0.53M
2011-01-21Post Ipo Equity· $39M
Recent News
2026-01-03
Company data provided by crunchbase